What have we been doing?

Genevant Sciences Announces Global Collaboration and License Agreement with Takeda to Develop Novel Nonviral Gene Therapies for Up to Two Rare Liver Diseases

Posted on 23rd August 2021

Genevant Sciences Announces Global Collaboration and License Agreement with Takeda to Develop Novel Nucleic Acid Therapeutics for Liver Fibrosis

Posted on 15th March 202112th March 2021

Gritstone and Genevant Sciences Announce License Agreement for COVID-19 Vaccine

Posted on 20th January 202120th January 2021

Sarepta Therapeutics and Genevant Sciences to Collaborate for LNP-Based Gene Editing Therapeutics

Posted on 13th January 202120th January 2021